How to Move Clinical Research into Communities That Would Truly Benefit

PharmaTalkRadio

English - February 04, 2019 15:30 - 35 minutes - 31.8 MB - ★★★★ - 16 ratings
Science pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Lessons Learned from a Veteran Biotech and Investor MD

Next Episode: Why Are Clinical Trials Not Typically a Care Option?

Jonathan Jackson, PhD, Director CARE Research Center, Massachusetts General Hospital, and Jim Kremidas, Executive Director, Association of Clinical Research Professionals (ACRP) sit down for a frank discussion on the benefits of offering clinical research in underserved communities. Many communities, whether affected by race, ethnicity, or socioeconomic lines, are underrepresented in clinical research. How can offering these care options enhance access to other resources in a broader sense and better educate these communities to the opportunities that clinical research provides?

This discussion was presented at the Clinical Research as a Care Option (CRAACO) meeting on April 11, 2018 in Cambridge, MA.

The 2019 CRAACO conference will take place April 29-30 in Raleigh-Durham, NC. Find out more here.